Vinny Samuel, MD
Critical Care Medicine · St Petersburg, FLNPI 1649324682
Payments from drug & device makers
What this record shows
This record is dominated by education: $141,020 of the $171,036 with a category attached, or 82.5%. Intuitive Surgical accounts for 87.7% of it on its own, with 43 other manufacturers making up the rest. Among critical care medicine clinicians in FL with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 405 payments — averaging $422.31 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Intuitive Surgical$150K
- Boehringer Ingelheim$15K
- AstraZeneca$821
- Johnson & Johnson$726
- Insmed, Inc.$710
- GSK$699
- plus $3K from 38 others
Across 6 payments — averaging $1200.00 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Actelion Pharmaceuticals, Ltd$7K
What the payments were for
- Speaking & faculty fees$14,5609%
- Travel & lodging$3,1482%
- Food & beverage$12,3087%
- Education$141,02082%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$171,036 in reported general payments places this provider in the 95th percentile of 618 critical care medicine providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ArikayceAmikacin Liposomal/Neb.Accessr | 19 | $284,501 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 58 | $74,845 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 47 | $63,681 |
| Dupixent SyringeDupilumab | 12 | $42,391 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 32 | $37,104 |
| Breo ElliptaFluticasone/Vilanterol | 16 | $16,582 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 11 | $14,547 |
| SymbicortBudesonide/Formoterol Fumarate | 28 | $9,288 |
| Spiriva HandihalerTiotropium Bromide | 11 | $7,529 |
| Arnuity ElliptaFluticasone Furoate | 18 | $6,602 |
| Albuterol Sulfate HfaAlbuterol Sulfate | 139 | $4,881 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 15 | $3,200 |
| Rifampin | 19 | $2,044 |
| Itraconazole | 14 | $1,961 |
| Ethambutol Hcl | 27 | $1,864 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Insmed, Inc.Arikayce | $710 | $284,50119 claims |
| GSKTrelegy Ellipta, Breo Ellipta, Anoro Ellipta, Arnuity Ellipta | $699 | $112,576103 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $821 | $72,96975 claims |
| Boehringer IngelheimStiolto Respimat | $14,590 | $37,10432 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 618 critical care medicine providers in Florida.
Other critical care medicine in St Petersburg
- Ala AhmadSt Petersburg$62K
- Hudman HooSt Petersburg$51K
- Eric SchillingSt Petersburg$14K
- Warren AbelSt Petersburg$9K
- Louis GuzziOrlando$635K
- Fortune AlabiKissimmee$587K
- Debabrata BandyopadhyayTampa$398K
- Fred UmehKissimmee$371K
- Amit TandonWesley Chapel$338K
- Omid ZadOrlando$325K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.